The Global Parkinson’s disease Treatment market is expected to be around US$ 7.90 Billion by 2028 at a CAGR of 6.1% in the given forecast period.
Advancing age, Strong family history with many members suffering from the disease. Prolonged exposure to chemicals and toxins are Major factors leading to the growth of the market Parkinson’s disease Treatment, High cost of treatment and lack of early diagnosis techniques are the major factor restricting the market growth.
Parkinson’s disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. Mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.
The global Parkinson’s disease Treatment market is segregated on the basis of Application as Hospitals, Healthcare Institutes, and Others. Based on Type the global Parkinson’s disease Treatment market is segmented in Dopamine Agonists, Levodopa, Glutamate Antagonist, Apomorphine, COMT Inhibitors Anticholinergics, MAO-B Inhibitors, and Other Drugs.
The global Parkinson’s disease Treatment market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Parkinson’s disease Treatment market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Teva, Boehringer Ingelheim, Impax, Abbvie, Valeant Pharmaceuticals, Lundbeck, Sun Pharma, Wockhardt, Acadia, UCB, and others are among the major players in the global Parkinson’s disease Treatment market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Parkinson’s disease Treatment Market has been segmented as below:
Parkinson’s disease Treatment Market, By Application
Parkinson’s disease Treatment Market, By Type
Parkinson’s disease Treatment Market, By Region
Parkinson’s disease Treatment Market, By Company
The report covers:
Report Scope:
The global Parkinson’s disease Treatment market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Parkinson’s disease Treatment market share. Major industry players with significant revenue share include Teva, Boehringer Ingelheim, Impax, Abbvie, Valeant Pharmaceuticals, Lundbeck, Sun Pharma, Wockhardt, Acadia, UCB, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Parkinson’s Disease Treatment Market, By Application
5.1 Introduction
5.2 Hospitals
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Healthcare Institutes
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Others
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Parkinson’s Disease Treatment Market, By Type
6.1 Introduction
6.2 Dopamine Agonists
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Levodopa
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Glutamate Antagonist
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Apomorphine
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 COMT Inhibitors Anticholinergics
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 MAO-B Inhibitors
6.7.1 Market Overview
6.7.2 Market Size and Forecast
6.8 Other Drugs
6.8.1 Market Overview
6.8.2 Market Size and Forecast
7. Parkinson’s Disease Treatment Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Parkinson’s disease Treatment, By Application
7.2.2 North America Parkinson’s disease Treatment, By Type
7.3 Europe
7.3.1 Europe Parkinson’s disease Treatment, By Application
7.3.2 Europe Parkinson’s disease Treatment, By Type
7.4 Asia-Pacific
7.4.1 Asia-Pacific Parkinson’s disease Treatment, By Application
7.4.2 Asia-Pacific Parkinson’s disease Treatment, By Type
7.5 Rest of the World
7.5.1 Rest of the World Parkinson’s disease Treatment, By Application
7.5.2 Rest of the World Parkinson’s disease Treatment, By Type
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Teva
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Boehringer Ingelheim
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Impax
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Abbvie
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Valeant Pharmaceuticals
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Lundbeck
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Sun Pharma
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Wockhardt
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Acadia
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 UCB
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Parkinson’s disease Treatment Market has been segmented as below:
Parkinson’s disease Treatment Market, By Application
Parkinson’s disease Treatment Market, By Type
Parkinson’s disease Treatment Market, By Region
Parkinson’s disease Treatment Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
